Takeda Pharmaceutical Company Ltd
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
- First Posted Date
- 2008-08-13
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Takeda
- Target Recruit Count
- 304
- Registration Number
- NCT00734071
Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Takeda
- Target Recruit Count
- 457
- Registration Number
- NCT00731120
Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
Phase 3
Completed
- Conditions
- Generalized Anxiety Disorder
- Interventions
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Takeda
- Target Recruit Count
- 781
- Registration Number
- NCT00730691
Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
Phase 3
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- First Posted Date
- 2008-08-04
- Last Posted Date
- 2011-07-29
- Lead Sponsor
- Takeda
- Target Recruit Count
- 600
- Registration Number
- NCT00727857
Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus
Phase 2
Terminated
- Conditions
- Diabetes Mellitus
- Interventions
- First Posted Date
- 2008-07-28
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 323
- Registration Number
- NCT00722917
Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- Takeda
- Target Recruit Count
- 836
- Registration Number
- NCT00707980
Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 156
- Registration Number
- NCT00708175
Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2013-05-24
- Lead Sponsor
- Takeda
- Target Recruit Count
- 441
- Registration Number
- NCT00707993
Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2011-07-29
- Lead Sponsor
- Takeda
- Target Recruit Count
- 1275
- Registration Number
- NCT00696241
A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2012-01-04
- Lead Sponsor
- Takeda
- Target Recruit Count
- 418
- Registration Number
- NCT00696384
© Copyright 2025. All Rights Reserved by MedPath